Concho’s Prospects Remain Solid and 4 Stock Analyses to Note

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX):  Baird said Allscripts Healthcare Solutions, Inc. has not commented on speculation, they have hired an advisor to speak with private equity firms and believe that the possibility is feasible. The firm said their leveraged buyout analysis easily supports an attractive deal and said investors should balk at anything less than $18 per share. Shares are Outperform rated and the price target is raised from $15 to $17 .

Concho Resources, Inc. (NYSE:CXO):  After meeting with Concho Resources, Inc.’s management, Wells Fargo believes that the company’s opportunity set and growth prospects still remain solid. The firm also thinks the company’s execution is stable and they maintain an Outperform rating on their shares.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Medtronic, Inc. (NYSE:MDT):  After meeting with Medtronic, Inc.’s  Chief Financial Officer, Wells Fargo believes that the consensus fiscal year earnings per share estimate appears conservative and they maintain an Outperform rating on the stock.

Monsanto Co. (NYSE:MON):  Susquehanna raised their price target on Monsanto Co., ahead of  their second quarter results. The firm expects investors to focus on 2013 guidance and expects initial guidance to be below their estimates. However,  Susquehanna said that Monsanto has a record of providing highly achievable targets and they should be boosted higher during the quarter. Shares are Positive rated.

Oasis Petroleum Inc. (NYSE:OAS):  Following meetings with management,  Baird said they remain incrementally positive on Oasis Petroleum Inc. The firm cited their differentiated value-added growth, cost structure, and ongoing consolidation in the Bakken. Shares are Outperform rated with a $39 price target.

Don’t Miss: The Week Ahead: Ben Bernanke Talks Monetary Policy, Crucial Holiday Quarter Kicks Off!